Katsiaryna Bykov, PharmD, ScD

Brigham and Women's Hospital, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• 1A-04 - Comparative Effectiveness of Current Glucose-Lowering Medications in Type 2 Diabetes Mellitus: Emulation of a modified GRADE trial

  Sunday, August 24, 2025
  11:15 AM - 11:30 AM ET

• 1E-02 - Risk of Opioid Overdose Associated with Concurrent Use of Hydrocodone and CYP3A4-inhibiting Calcium Channel Blockers

  Sunday, August 24, 2025
  10:45 AM - 11:00 AM ET

• 1E-03 - Opioid Overdose Associated With Concomitant Use of Hydrocodone And Selective Serotonin Reuptake Inhibitors

  Sunday, August 24, 2025
  11:00 AM - 11:15 AM ET

• 3F-06 - Oral Anticoagulation and Risk of Adverse Clinical Outcomes in Patients with Venous Thromboembolism

  Monday, August 25, 2025
  9:30 AM - 9:45 AM ET

• 5E-06 - Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in patients with Type 2 Diabetes

  Tuesday, August 26, 2025
  9:45 AM - 10:00 AM ET